The Pittsburgh Sleep Quality Index (PSQI) — one of the most widely used self-report instruments in sleep medicine — faces fundamental conceptual and methodological problems that limit its utility in modern sleep research, according to a critical review in Sleep Medicine Reviews.
Since its publication in 1989 by Buysse and colleagues, the PSQI has been cited in tens of thousands of studies. But five interrelated issues have accumulated over 35 years of use, and the review argues that the field needs to reframe how the instrument is scored and interpreted.
What they found
The review, led by Matteo Carpi (Sapienza University of Rome) and colleagues from Italy and Portugal, identifies five core problems:
- No construct model: There is no clearly specified theoretical model of what “sleep quality” actually is. The PSQI was developed empirically, not from a theory of sleep health, so it is unclear what the global score represents conceptually
- Proxy for insomnia: The PSQI is frequently and inappropriately used as a standalone screening tool for insomnia or sleep disturbance, despite not being designed or validated for that purpose
- Fragile cutoff: The conventional global score cutoff of >5 for “poor sleep” has limited interpretive reliability. Its sensitivity and specificity vary widely across populations and clinical contexts
- Factorial instability: The component scoring logic varies across studies, and the factor structure of the PSQI (how items group into dimensions) is not stable — different studies find different factor solutions
- Recall bias and redundancy: The retrospective estimates of sleep continuity (duration, latency, efficiency) are vulnerable to recall errors and overlap with information captured by other items, raising questions about what is being measured independently
The path forward
The authors propose shifting from the vague construct of “sleep quality” toward a multidimensional sleep health framework — a concept that recognizes sleep as a positive health behavior with multiple measurable dimensions (regularity, satisfaction, alertness, timing, efficiency, duration) rather than a single continuum from good to bad.
Within this framework, they recommend:
- Reframing PSQI outputs within a theoretically grounded sleep health perspective
- Adopting alternative scoring and reporting strategies that align with contemporary sleep assessment models
- Using the PSQI as one component of a broader assessment battery, not as a standalone diagnostic or screening instrument
Why it matters
The PSQI remains the default choice for sleep assessment in thousands of studies across medicine, psychology, and public health. The decisions researchers make about how to use, score, and interpret it directly shape what the field thinks it knows about sleep and health. This review does not call for abandoning the PSQI, but for using it with greater awareness of its limitations and within a more conceptually sound framework.
For clinicians and researchers, the takeaway is practical: a global PSQI score >5 is a useful rough indicator but should not be treated as a definitive measure of sleep disturbance or a proxy for insomnia. The individual component scores and their relationship to the patient’s clinical presentation matter more than the global cutoff.
Limits
This is a narrative review, not a systematic meta-analysis. The authors’ recommendations are expert opinion, not empirically derived guidelines. The PSQI remains a validated instrument for its intended purpose — it is the misuse and over-interpretation that the review critiques.
Bottom line
After 35 years, the PSQI remains a useful tool, but the field should move beyond treating it as a simple “good vs. poor sleep” screener. Reframing its outputs within a multidimensional sleep health framework and using alternative scoring strategies would improve its conceptual alignment with contemporary sleep medicine.
Source
Carpi M, Fontoura Dias S, Ruivo Marques D, Liguori C. Thirty-five years of the Pittsburgh sleep quality index: a critical appraisal and a path forward for its contemporary use. Sleep Med Rev. 2026 Jun 17;89:102326. DOI: 10.1016/j.smrv.2026.102326. PMID: 42320263.